03692.HK_Providing professional financial news and data related to 03692.HK, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Hansoh Pharmaceutical (03692.HK): NMPA Accepts New Drug Application for Orlotide Injection

Tags：

Hansoh Pharmaceutical 03692.HK

2026-06-04

ETF
ChinaAMC CSI Robot ETF (562500) rises 1.24% in morning trading, aiming for a third consecutive gain
ETF
ICBCCS China Science And Technology Innovation Board 50 Component ETF (588050) rises 1.58%, aiming for a third consecutive gain, with the latest scale reaching 7.857 billion yuan
ETF
E Fund CSI Consumer Electronic Theme ETF (562950) rises 1.54%, aiming for a third consecutive gain, with a scale increase of 395 million yuan over the past 2 weeks
ETF
Hwabao WP CSI Electronic 50 ETF(515260) rises 2.23%, with a scale increase of 186 million yuan over the past 2 weeks
ETF
China Universal CSI Chip Industry ETF (516920) rises 1.14%, aiming for a third consecutive gain
ETF
GF CSI Semiconductor Material Equipment Theme ETF(560780) rises 1.21% in morning trading, aiming for a third consecutive gain
Finance
EASOU TECH (02550.HK) plans to issue in total 90 million shares
Finance
KINETIC DEV (01277.HK) plans to issue in total 169.51 million shares by placement, with estimated net proceeds of HKD 309.3 million
Finance
Hansoh Pharmaceutical (03692.HK): NMPA Accepts New Drug Application for Orlotide Injection
Finance
Heng Pharmaceutical-B (02256.HK) Presents Novel Combination Modelling Framework for ABSK-011 at PAGE Conference

Scan QR Code

Download App